Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

melanoma

  • Open Access
    Inhibitory Effect of Clopidogrel, a P2Y12 Receptor Antagonist, on Hematogenic Metastasis in B16-BL6 Mouse Melanoma Cells
    NORIKO YOSHIKAWA, MINGYU XIA and KAZUKI NAKAMURA
    In Vivo May 2025, 39 (3) 1325-1330; DOI: https://doi.org/10.21873/invivo.13936
  • Open Access
    Correlation of Psychosomatic Factors and Personality Traits With the Severity of Melanoma
    KONSTANTINOS KONTOANGELOS, VASILIKI NIKOLAOU, AGGELIKI SYRGIANNI, SOFIA TSIORI, CHARALABOS PAPAGEORGIOU and ALEXANDER STRATIGOS
    In Vivo November 2024, 38 (6) 2844-2852; DOI: https://doi.org/10.21873/invivo.13765
  • Open Access
    Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells
    DAVID TOVAR-PARRA and MARION ZAMMIT-MANGION
    In Vivo July 2024, 38 (4) 1579-1593; DOI: https://doi.org/10.21873/invivo.13608
  • Open Access
    Systemic Scleroderma Induced by Nivolumab in Malignant Melanoma
    THIBAUD LOUPRET, ROMAIN BOISSEAU, JEAN-GUILLAUME LOPEZ, PHILIPPE BERTIN and PASCALE VERGNE-SALLE
    In Vivo May 2024, 38 (3) 1451-1453; DOI: https://doi.org/10.21873/invivo.13589
  • Open Access
    UVC-Protective Activity of Lemongrass Among 12 Fat-soluble Herbal Extracts: Rapid Decay Due to Cytotoxicity
    YUSEI OTAKA, MAKI IZAWA, HIROSHI SAKAGAMI, NORIYOSHI SHIBA, NOBUTOSHI TAKAHASHI, SEI-ICHI TANUMA, SHIGERU AMANO, SHIN UOTA, MEGUMI INOMATA, SATOSHI YOKOSE, KATSUYOSHI SUNAGA, SHINICHIRO HAYASHI, YUKARI KOGA-OGAWA, GIICHIROU NAKAYA and SHINJI KITO
    In Vivo November 2023, 37 (6) 2464-2472; DOI: https://doi.org/10.21873/invivo.13353
  • Open Access
    Comprehensive Study of Anti-UVC Activity and Cytotoxicity of Hot-water Soluble Herb Extracts
    MAKI IZAWA, YUSEI OTAKA, HIROSHI SAKAGAMI, SEI-ICHI TANUMA, SHIGERU AMANO, SHIN UOTA, MEGUMI INOMATA, YUKA KATO, HIROSHI KADOKURA, SATOSHI YOKOSE, KATSUYOSHI SUNAGA, YUKARI KOGA-OGAWA, GIICHIROU NAKAYA and SHINJI KITO
    In Vivo July 2023, 37 (4) 1540-1551; DOI: https://doi.org/10.21873/invivo.13239
  • Open Access
    Cutaneous Melanoma of the Lip: A SEER Analysis of Epidemiology and Survival Outcomes With Focus on Surgery and Other Treatment Options
    JUAN A. VISCARDI, MATTEO SCAMPA, SOLANGE N. WALZ, JEROME MARTINEAU, PIETRO G. DI SUMMA, SALVATORE GIORDANO, DANIEL F. KALBERMATTEN and CARLO M. ORANGES
    In Vivo May 2023, 37 (3) 1164-1172; DOI: https://doi.org/10.21873/invivo.13191
  • Open Access
    Prominent Anti-UVC Activity of Lignin Degradation Products
    HIROSHI SAKAGAMI, SHIGERU AMANO, SHIN UOTA, SEI-ICHI TANUMA, MEGUMI INOMATA, AYAKA SHINDO, MIDORI KUSANO, YUJI KIKKAWA, MISAKI HORIUCHI and TAKAFUMI OOKA
    In Vivo November 2022, 36 (6) 2689-2699; DOI: https://doi.org/10.21873/invivo.13004
  • Open Access
    Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells
    AYAKA SHINDO, MIDORI KUSANO, HIROSHI SAKAGAMI, SHIGERU AMANO, MEGUMI INOMATA, MASAYO ABE, MASASHI OKAZAWA and TAKAFUMI OOKA
    In Vivo September 2022, 36 (5) 2116-2125; DOI: https://doi.org/10.21873/invivo.12937
  • You have access
    3’UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma
    DAVID TOVAR-PARRA, SEBASTIÁN RAMIRO GIL-QUIÑONES, JOHN NOVA and LUZ D. GUTIÉRREZ-CASTAÑEDA
    In Vivo May 2021, 35 (3) 1529-1536; DOI: https://doi.org/10.21873/invivo.12406

Pages

  • Next
  • 1
  • 2
  • 3
In Vivo

© 2025 In Vivo

Powered by HighWire